OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Current state in the development of candidate therapeutic HPV vaccines
Andrew Yang, Jessica Jeang, Yeu-Yao Cheng, et al.
Expert Review of Vaccines (2016) Vol. 15, Iss. 8, pp. 989-1007
Open Access | Times Cited: 110
Andrew Yang, Jessica Jeang, Yeu-Yao Cheng, et al.
Expert Review of Vaccines (2016) Vol. 15, Iss. 8, pp. 989-1007
Open Access | Times Cited: 110
Showing 1-25 of 110 citing articles:
Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy
Asmita Pal, Rita Kundu
Frontiers in Microbiology (2020) Vol. 10
Open Access | Times Cited: 451
Asmita Pal, Rita Kundu
Frontiers in Microbiology (2020) Vol. 10
Open Access | Times Cited: 451
Cervical Cancer Immunotherapy: Facts and Hopes
Louise Ferrall, Ken Y. Lin, Richard B.S. Roden, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 18, pp. 4953-4973
Open Access | Times Cited: 257
Louise Ferrall, Ken Y. Lin, Richard B.S. Roden, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 18, pp. 4953-4973
Open Access | Times Cited: 257
Human papillomavirus molecular biology
Mallory E. Harden, Karl Münger
Mutation Research/Reviews in Mutation Research (2016) Vol. 772, pp. 3-12
Open Access | Times Cited: 221
Mallory E. Harden, Karl Münger
Mutation Research/Reviews in Mutation Research (2016) Vol. 772, pp. 3-12
Open Access | Times Cited: 221
Perspectives for therapeutic HPV vaccine development
Andrew Yang, Emily Farmer, T.‐C. Wu, et al.
Journal of Biomedical Science (2016) Vol. 23, Iss. 1
Open Access | Times Cited: 191
Andrew Yang, Emily Farmer, T.‐C. Wu, et al.
Journal of Biomedical Science (2016) Vol. 23, Iss. 1
Open Access | Times Cited: 191
Mechanistic role of HPV-associated early proteins in cervical cancer: Molecular pathways and targeted therapeutic strategies
Rahul Bhattacharjee, Sabya Sachi Das, Smruti Sudha Biswal, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 174, pp. 103675-103675
Open Access | Times Cited: 118
Rahul Bhattacharjee, Sabya Sachi Das, Smruti Sudha Biswal, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 174, pp. 103675-103675
Open Access | Times Cited: 118
Advancing the Fight Against Cervical Cancer: The Promise of Therapeutic HPV Vaccines
Qian Zheng, Misi He, Zejia Mao, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 92-92
Open Access | Times Cited: 2
Qian Zheng, Misi He, Zejia Mao, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 92-92
Open Access | Times Cited: 2
Immunotherapy in endometrial cancer: new scenarios on the horizon
Chiara Di Tucci, Carmela Capone, Giulia Galati, et al.
Journal of Gynecologic Oncology (2019) Vol. 30, Iss. 3
Open Access | Times Cited: 115
Chiara Di Tucci, Carmela Capone, Giulia Galati, et al.
Journal of Gynecologic Oncology (2019) Vol. 30, Iss. 3
Open Access | Times Cited: 115
Human papilloma virus: A review study of epidemiology, carcinogenesis, diagnostic methods, and treatment of all HPV-related cancers
Maryam Soheili, Hossein Keyvani, Marzieh Soheili, et al.
Medical Journal of the Islamic Republic of Iran (2021)
Open Access | Times Cited: 79
Maryam Soheili, Hossein Keyvani, Marzieh Soheili, et al.
Medical Journal of the Islamic Republic of Iran (2021)
Open Access | Times Cited: 79
Novel Therapeutics for Recurrent Cervical Cancer: Moving Towards Personalized Therapy
Alexander C. Cohen, B.M. Roane, Charles A. Leath
Drugs (2020) Vol. 80, Iss. 3, pp. 217-227
Open Access | Times Cited: 77
Alexander C. Cohen, B.M. Roane, Charles A. Leath
Drugs (2020) Vol. 80, Iss. 3, pp. 217-227
Open Access | Times Cited: 77
Contributions of the international plant science community to the fight against human infectious diseases – part 1: epidemic and pandemic diseases
Maria Lobato‐Gómez, Xin Huang, Derry Alvarez, et al.
Plant Biotechnology Journal (2021) Vol. 19, Iss. 10, pp. 1901-1920
Open Access | Times Cited: 59
Maria Lobato‐Gómez, Xin Huang, Derry Alvarez, et al.
Plant Biotechnology Journal (2021) Vol. 19, Iss. 10, pp. 1901-1920
Open Access | Times Cited: 59
Current and future direction in treatment of HPV-related cervical disease
Niloofar Khairkhah, Azam Bolhassani, Reza Najafipour
Journal of Molecular Medicine (2022) Vol. 100, Iss. 6, pp. 829-845
Open Access | Times Cited: 54
Niloofar Khairkhah, Azam Bolhassani, Reza Najafipour
Journal of Molecular Medicine (2022) Vol. 100, Iss. 6, pp. 829-845
Open Access | Times Cited: 54
Immune-based therapies in penile cancer
Vidhu B. Joshi, Philippe E. Spiess, Andrea Necchi, et al.
Nature Reviews Urology (2022) Vol. 19, Iss. 8, pp. 457-474
Open Access | Times Cited: 43
Vidhu B. Joshi, Philippe E. Spiess, Andrea Necchi, et al.
Nature Reviews Urology (2022) Vol. 19, Iss. 8, pp. 457-474
Open Access | Times Cited: 43
Current status and future directions for the development of human papillomavirus vaccines
Rui Wang, Hongpeng Huang, Chulin Yu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
Rui Wang, Hongpeng Huang, Chulin Yu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
Annexin A5 as an immune checkpoint inhibitor and tumor-homing molecule for cancer treatment
Tae Heung Kang, Jung Hwa Park, Andrew Yang, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 67
Tae Heung Kang, Jung Hwa Park, Andrew Yang, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 67
Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases
Max A. Cheng, Emily Farmer, Claire Y.‐H. Huang, et al.
Human Gene Therapy (2018) Vol. 29, Iss. 9, pp. 971-996
Open Access | Times Cited: 61
Max A. Cheng, Emily Farmer, Claire Y.‐H. Huang, et al.
Human Gene Therapy (2018) Vol. 29, Iss. 9, pp. 971-996
Open Access | Times Cited: 61
Peptide-Based Nanovaccines in the Treatment of Cervical Cancer: A Review of Recent Advances
Jiahui Zhang, Jingyi Fan, Mariusz Skwarczyński, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 869-900
Open Access | Times Cited: 36
Jiahui Zhang, Jingyi Fan, Mariusz Skwarczyński, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 869-900
Open Access | Times Cited: 36
HPV and Cervical Cancer: Molecular and Immunological Aspects, Epidemiology and Effect of Vaccination in Latin American Women
Christian David Hernández-Silva, Adrián Ramírez-de-Arellano, Ana Laura Pereira-Suárez, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 327-327
Open Access | Times Cited: 6
Christian David Hernández-Silva, Adrián Ramírez-de-Arellano, Ana Laura Pereira-Suárez, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 327-327
Open Access | Times Cited: 6
The current state of therapeutic and T cell-based vaccines against human papillomaviruses
Andrew Yang, Emily Farmer, John Lin, et al.
Virus Research (2016) Vol. 231, pp. 148-165
Open Access | Times Cited: 58
Andrew Yang, Emily Farmer, John Lin, et al.
Virus Research (2016) Vol. 231, pp. 148-165
Open Access | Times Cited: 58
Antigenic Peptide Prediction From E6 and E7 Oncoproteins of HPV Types 16 and 18 for Therapeutic Vaccine Design Using Immunoinformatics and MD Simulation Analysis
Basit Jabbar, Shazia Rafique, Outi M. H. Salo‐Ahen, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 57
Basit Jabbar, Shazia Rafique, Outi M. H. Salo‐Ahen, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 57
Advances in Designing and Developing Vaccines, Drugs and Therapeutic Approaches to Counter Human Papilloma Virus
Maryam Dadar, Sandip Chakraborty, Kuldeep Dhama, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 56
Maryam Dadar, Sandip Chakraborty, Kuldeep Dhama, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 56
The safety and immunogenicity of Quadrivalent HPV (qHPV) vaccine in systemic lupus erythematosus
J. Patricia Dhar, Lynnette Essenmacher, Renee Dhar, et al.
Vaccine (2017) Vol. 35, Iss. 20, pp. 2642-2646
Closed Access | Times Cited: 50
J. Patricia Dhar, Lynnette Essenmacher, Renee Dhar, et al.
Vaccine (2017) Vol. 35, Iss. 20, pp. 2642-2646
Closed Access | Times Cited: 50
Whole-Genome Analysis of Human Papillomavirus Types 16, 18, and 58 Isolated from Cervical Precancer and Cancer Samples in Chinese Women
Ying Liu, Yaqi Pan, Weijiao Gao, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 49
Ying Liu, Yaqi Pan, Weijiao Gao, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 49
Therapeutic vaccines and immune checkpoints inhibition options for gynecological cancers
Chiara Di Tucci, Michele Carlo Schiavi, Pierangelo Faiano, et al.
Critical Reviews in Oncology/Hematology (2018) Vol. 128, pp. 30-42
Closed Access | Times Cited: 47
Chiara Di Tucci, Michele Carlo Schiavi, Pierangelo Faiano, et al.
Critical Reviews in Oncology/Hematology (2018) Vol. 128, pp. 30-42
Closed Access | Times Cited: 47
Activating STING/TBK1 suppresses tumor growth via degrading HPV16/18 E7 oncoproteins in cervical cancer
Xiaodan Huang, Lanqing Huo, Bei-Bei Xiao, et al.
Cell Death and Differentiation (2023) Vol. 31, Iss. 1, pp. 78-89
Closed Access | Times Cited: 13
Xiaodan Huang, Lanqing Huo, Bei-Bei Xiao, et al.
Cell Death and Differentiation (2023) Vol. 31, Iss. 1, pp. 78-89
Closed Access | Times Cited: 13
Lipid Nanoparticles Outperform Electroporation in Delivering Therapeutic HPV DNA Vaccines
Mingzhu Li, Lei Liu, Xiaoli Li, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 666-666
Open Access | Times Cited: 5
Mingzhu Li, Lei Liu, Xiaoli Li, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 666-666
Open Access | Times Cited: 5
